Page 1 | Search Results | Journal of Experimental Medicine | Rockefeller University Press

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung

Meera G. Nair, Yurong Du, Jacqueline G. Perrigoue, Colby Zaph, Justin J. Taylor, Michael Goldschmidt, Gary P. Swain, George D. Yancopoulos, David M. Valenzuela, Andrew Murphy, Margaret Karow, Sean Stevens, Edward J. Pearce, David Artis

J Exp Med (2009) 206 (5): 1201.

https://doi.org/10.1084/jem.2008204841009c

Published: 20 April 2009

View article titled, Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung

Journal Articles

Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung

Meera G. Nair, Yurong Du, Jacqueline G. Perrigoue, Colby Zaph, Justin J. Taylor, Michael Goldschmidt, Gary P. Swain, George D. Yancopoulos, David M. Valenzuela, Andrew Murphy, Margaret Karow, Sean Stevens, Edward J. Pearce, David Artis

J Exp Med (2009) 206 (4): 937–952.

https://doi.org/10.1084/jem.20082048

Published: 06 April 2009

View article titled, Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung

Includes: Supplementary data

Journal Articles

The transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis

Benno Weigmann, Hans A. Lehr, George Yancopoulos, David Valenzuela, Andrew Murphy, Sean Stevens, Jan Schmidt, Peter R. Galle, Stefan Rose-John, Markus F. Neurath

J Exp Med (2008) 205 (9): 2099–2110.

https://doi.org/10.1084/jem.20072484

Published: 18 August 2008

View article titled, The transcription factor NFATc2 controls IL-6–dependent T cell activation in experimental colitis

Includes: Supplementary data